BIOTRONIK has unveiled its brand new Edora pacemakers and cardiac resynchronization therapy pacemakers (CRT-Ps) following CE Mark approval in Europe. These devices feature BIOTRONIK’s ProMRI ...
Biotronik today shared preclinical results for its LivIQ leadless pacemaker system at Heart Rhythm Society (HRS) 2026 in ...
LAKE OSWEGO, Ore., July 6, 2023 /PRNewswire/ -- BIOTRONIK today announced U.S. Food and Drug Administration (FDA) approval of its portfolio of Amvia Edge pacemakers and cardiac resynchronization ...
Hosted on MSN
BIOTRONIK begins trial of LivIQ pacemaker system
BIOTRONIK has commenced its global pivotal trial assessing the LivIQ leadless pacemaker system, a next-generation single device solution intended for delivering atrioventricular (AV) synchrony through ...
International BIO-LivIQ Study Will Generate Evidence for Global LivIQ Leadless Pacemaker Approvals Far-Field Sensing and AV-Synchronous Pacing Performance Will be Validated by Real World Clinical Data ...
Biotronik announced today that it received FDA approval for its Acticor Sky and Rivacor implantable defibrillator systems.
LAKE OSWEGO, Ore.--(BUSINESS WIRE)--BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the first US patient has been implanted with the company’s Eluna pacemaker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results